Slingshot Biosciences Names Dr. Nimisha Srivastava as New CEO
Image
Emeryville, Calif. – September 25, 2026 -- Slingshot Biosciences has appointed Dr. Nimisha Srivastava as Chief Executive Officer, effective September 23, 2026, elevating the company's former Chief Operating Officer to its top leadership post.
Srivastava succeeds Glenn Bilawsky as CEO of the flow cytometry controls maker
Glenn Bilawsky is transitioning out of the CEO role at Slingshot Biosciences, a company specializing in precision-engineered cell mimics used as reference materials in flow cytometry. The Board of Directors credited Bilawsky's leadership contributions during his tenure.